Stadler J K, Adelberg E A
Proc Natl Acad Sci U S A. 1972 Jul;69(7):1929-33. doi: 10.1073/pnas.69.7.1929.
Synchronized cells of the mouse leukemic cell line, L5178Y, were examined for their ability to undergo virus-induced fusion. Fusion capacity (defined as the percentage of the original unicellular population that is induced by virus to participate in a fusion event) was measured in cells that were (i) arrested by colcemid, (ii) released from colcemid block, and (iii) released from thymidine block. The results show that fusion capacity is minimal during G1 phase (less than 10%), and rises to a maximum (69%) in arrested mitosis. Treatment of nonsynchronized cells with trypsin increased their fusion capacity to the level characteristic of cells arrested in mitosis. Colcemid-arrested cells produced twice as many hybrid clones as nonsynchronized cells after they were plated in selective medium.
对小鼠白血病细胞系L5178Y的同步化细胞进行检测,以观察它们发生病毒诱导融合的能力。融合能力(定义为由病毒诱导参与融合事件的原始单细胞群体的百分比)在以下细胞中进行测量:(i) 被秋水仙酰胺阻滞的细胞;(ii) 从秋水仙酰胺阻滞中释放的细胞;(iii) 从胸腺嘧啶核苷阻滞中释放的细胞。结果表明,融合能力在G1期最小(低于10%),在有丝分裂阻滞期升至最高(69%)。用胰蛋白酶处理非同步化细胞可使其融合能力提高到有丝分裂阻滞细胞的特征水平。在接种到选择培养基中后,秋水仙酰胺阻滞的细胞产生的杂交克隆是非同步化细胞的两倍。